CD33 and acute myeloid leukemia: For example, the AML antigens CD33 and CD123 did not meet our stringent overexpression standards for malignant hematopoietic stem and progenitor cells (HSPCs), most likely because of their expression in healthy HSPCs as well (80, 252).